RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock : Bullish and Bearish Analyst Opinions

These companies are either losing too much money in a tough tape, had bad quarters, failed to deliver on big promises, or are trading like meme stocks. In a macro environment threatened by inflation and oil shocks, the market has zero tolerance for cash-burning, speculative companies. Capital will aggressively rotate out of unprofitable tech and biotech into companies with real earnings and strong balance sheets. AVOID. Do not buy the dip on cash-burning or speculative stocks in a hostile, inflation-wary market. A sudden drop in interest rates or a rapid resolution to geopolitical conflicts could spark a risk-on rally, causing these heavily shorted or beaten-down names to squeeze higher.